Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric Cancer After PD-1 Antibody Failed
NCT06102759
·
clinicaltrials.gov ↗
RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Gastric Cancer
Interventions
DRUG:
Adebrelimab，Fruquintinib
Sponsor
Tianjin Medical University Cancer Institute and Hospital